UK drugmaker AstraZeneca is in talks to combine with US rival Bristol Myers Squibb in a deal that would create one of the ...

Bristol-Myers Squibb has formed an R&D partnership with GentiBio, aimed at developing regulatory T cel (Treg) therapies for inflammatory bowel disease (IBD). The deal includes an undisclosed upfront ...

The MonumenTAL-6 results add to the growing body of evidence touting Talvey and Tecvayli’s use in earlier multiple myeloma treatment lines.

Rugged systems require safer, more durable battery chemistries along with more robust packaging that can handle harsh ...

Q2 2026 earnings call recap: guidance cut, CEO transition, oncology pipeline updates, and key catalysts—read insights and what’s next.

Bristol Myers Squibb has moved to take full control of the CAR-T therapy it partners with 2seventy bio, agreeing to buy the biotech for around $286 million. The $5.00-per-share offer – announced at ...

AstraZeneca Bristol Myers Squibb merger talks could create a $400 billion pharmaceutical giant — the largest in history — ...

SHENZHEN, GUANGDONG, CHINA, July 29, 2026 /EINPresswire.com/ -- The modern healthcare landscape is undergoing a silent ...

Short commutes and easy access significantly boost public transport use in Bengaluru. Journeys under thirty minutes are ...

Great work, chemists! Two of the largest petrochemical makers in the Middle East—Sabic and Borouge—say they have been able to ...

Guido Oelkers, Ph.D., appointed to BioNTech Management Board as Chief Executive Officer, taking office by February 1, 2027, at the latestAdvanced ...

At the heart of this technological shift is the rechargeable battery—a sophisticated electrochemical system capable of multiple charge and discharge cycles. Driven primarily by lithium-ion, lithium ...